Ekso Bionics Holdings Inc (NASDAQ: EKSO) kicked off on Tuesday, up 93.77% from the previous trading day, before settling in for the closing price of $5.46. Over the past 52 weeks, EKSO has traded in a range of $2.73-$14.97.
During the last 5-year period, the sales growth of Healthcare Sector giant was 25.99%. While this was happening, its average annual earnings per share was recorded 74.17%. With a float of $3.13 million, this company’s outstanding shares have now reached $3.39 million.
Ekso Bionics Holdings Inc (EKSO) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Medical Instruments & Supplies Industry. The insider ownership of Ekso Bionics Holdings Inc is 7.65%, while institutional ownership is 10.56%. The most recent insider transaction that took place on Dec 09 ’25, was worth 1,269. In this transaction Chief Operating Officer of this company sold 270 shares at a rate of $4.70, taking the stock ownership to the 26,941 shares. Before that another transaction happened on Dec 09 ’25, when Company’s Chief Financial Officer sold 1,238 for $4.70, making the entire transaction worth $5,819. This insider now owns 24,771 shares in total.
Ekso Bionics Holdings Inc (EKSO) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -2.1 earnings per share (EPS), lower than consensus estimate (set at -1.2) by -0.9. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 74.17% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 80.74% during the next five years compared to 25.99% growth over the previous five years of trading.
Ekso Bionics Holdings Inc (NASDAQ: EKSO) Trading Performance Indicators
Take a look at Ekso Bionics Holdings Inc’s (EKSO) current performance indicators. Last quarter, stock had a quick ratio of 1.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.57, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -0.41 in one year’s time.
Technical Analysis of Ekso Bionics Holdings Inc (EKSO)
Looking closely at Ekso Bionics Holdings Inc (NASDAQ: EKSO), its last 5-days average volume was 22.83 million, which is a jump from its year-to-date volume of 0.59 million. As of the previous 9 days, the stock’s Stochastic %D was 85.17%.
During the past 100 days, Ekso Bionics Holdings Inc’s (EKSO) raw stochastic average was set at 78.35%, which indicates a significant increase from 73.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.62 in the past 14 days, which was higher than the 0.39 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.89, while its 200-day Moving Average is $4.76. However, in the short run, Ekso Bionics Holdings Inc’s stock first resistance to watch stands at $12.92. Second resistance stands at $15.26. The third major resistance level sits at $17.82. If the price goes on to break the first support level at $8.02, it is likely to go to the next support level at $5.46. Now, if the price goes above the second support level, the third support stands at $3.12.
Ekso Bionics Holdings Inc (NASDAQ: EKSO) Key Stats
The company with the Market Capitalisation of 35.89 million has total of 2,623K Shares Outstanding. Its annual sales at the moment are 17,930 K in contrast with the sum of -11,330 K annual income. Company’s last quarter sales were recorded 4,230 K and last quarter income was -1,420 K.
